¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°, Á¦Çüº°, ÀûÀÀÁõº°, Åõ¿© °æ·Îº°, À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°
Global Antihistamine Drugs Market, By Drug Class, By Form, By Indication, By Route of Administration, By Type, By Distribution Channel, By Geography
»óǰÄÚµå
:
1699444
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 02¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀåÀº 2025³â¿¡´Â 1,017¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â±îÁö´Â 1,678¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â¿¡ 7.4%ÀÇ CAGR(¿¬Æò±Õ ¼ºÀå·ü)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¸®Æ÷Æ® ¹üÀ§
¸®Æ÷Æ® »ó¼¼
±âÁØ¿¬µµ
2024³â
2025³â ½ÃÀå ±Ô¸ð
1,017¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR :
7.40%
2032³â ±Ý¾× ¿¹Ãø
1,678¾ï ´Þ·¯
µµÇ¥. ¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°(2025³â)
Ç×È÷½ºÅ¸¹ÎÁ¦´Â Àçä±â, °¡·Á¿òÁõ, Ä๰, ´«¹° µîÀÇ ¾Ë·¹¸£±â Áõ»ó Ä¡·á¿¡ »ç¿ëµÇ´Â ¾à¹°ÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. Ç×È÷½ºÅ¸¹ÎÁ¦´Â ¾Ë·¹¸£±â ¹ÝÀÀ½Ã ºÐºñµÇ´Â ü³» ¹°ÁúÀÎ È÷½ºÅ¸¹ÎÀÇ ÀÛ¿ëÀ» ¾ïÁ¦ÇÏ¿© È¿°ú¸¦ ¹ßÈÖÇÕ´Ï´Ù. Ç×È÷½ºÅ¸¹ÎÁ¦´Â Å©°Ô 1¼¼´ë Ç×È÷½ºÅ¸¹ÎÁ¦¿Í 2¼¼´ë Ç×È÷½ºÅ¸¹ÎÁ¦ µÎ °¡Áö·Î ³ª´¹´Ï´Ù. Ç×È÷½ºÅ¸¹ÎÁ¦´Â ¾àÀÇ À¯Çü°ú °µµ¿¡ µû¶ó ÀϹÝÀǾàǰ°ú 󹿾àÀ¸·Î ³ª´¹´Ï´Ù. Á¤Á¦, ĸ½¶, ¾×»ó, Á¡ºñÁ¦, Á¡¾ÈÁ¦, Á¡¾ÈÁ¦ µî ´Ù¾çÇÑ ÇüŰ¡ ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ:
Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀåÀº ¾Ë·¹¸£±â À¯º´·ü Áõ°¡, ½ÅÁ¦Ç° Ãâ½Ã, Çõ½ÅÀûÀÎ Á¦Çü ½ÂÀÎ µîÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2021³â 6¿ù ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº ó¹æ¾à¿¡¼ ºñ󹿾àÀ¸·ÎÀÇ ºÎºÐ ÀüȯÀ¸·Î ¾Ë·ÁÁø °úÁ¤À» ÅëÇØ ºñ󹿾à¿ë ºñ°¿ë Ç×È÷½ºÅ¸¹ÎÁ¦¸¦ ½ÂÀÎÇß½À´Ï´Ù. ¹Ì±¹ FDA´Â ¾Æ½ºÅ×ÇÁ·Î(¾ÆÁ©¶ó½ºÆ¾ ¿°»ê¿° ºñ° ºÐ¹«Á¦, 0.15%)¸¦ 6¼¼ ÀÌ»óÀÇ ¼ºÀΰú ¾î¸°ÀÌÀÇ °èÀý¼º ¹× ¿¬Áß ¾Ë·¹¸£±â¼º ºñ¿°(¾Ë·¹¸£±â¶ó°íµµ ÇÔ)¿¡ ´ëÇØ ½ÂÀÎÇß½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦(Ç×È÷½ºÅ¸¹ÎÁ¦) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¸ÅÃâ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù.
ÀÌ º¸°í¼´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·«°ú °°Àº ´ÙÀ½ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷¿¡´Â Bayer AG, Almirall, S.A., GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer Inc., Sun Pharmaceutical Industries Limited, Merck &Co., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Viatris Inc., Arlak Biotech, Aden Healthcare, Sandoz Group AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories, Cipla µîÀÌ Æ÷ÇԵ˴ϴÙ.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¼¼°è Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå °³¿ä
¸®Æ÷Æ® ¼³¸í
°³¿ä
½ÃÀå ±âȸ ¸Ê
Á¦3Àå ÁÖ¿ä ÀλçÀÌÆ®
½ÃÀå ¿ªÇÐ
¿µÇ⠺м®
PEST ºÐ¼®
PorterÀÇ »ê¾÷ ºÐ¼®
±â¼úÀÇ Áøº¸
ÇÕº´, Àμö, Çù¾÷ ½Ã³ª¸®¿À
ÃÖ±Ù Á¦Ç° ½ÂÀÎ
±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
°¢ Áö¿ªÀÇ ÁÖ¿ä ±â¾÷ÀÇ Æ¯Á¤
¼öÃâÀÔ ºÐ¼®
±ÔÁ¦ ½Ã³ª¸®¿À
°¡°Ý ºÐ¼®
Á¦Ç° ¸®ÄÝ
Á¦4Àå ¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå, ¾àÁ¦ Ŭ·¡½ºº°, 2020-2032³â
H-1 Ç×È÷½ºÅ¸¹ÎÁ¦
Á¦1¼¼´ë
Á¦2¼¼´ë
H-2 Ç×È÷½ºÅ¸¹ÎÁ¦
Á¦5Àå ¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå, Çüź°, 2020-2032³â
¾×ü
ÅÂºí¸´
ĸ½¶
°Ö
ºñ° ½ºÇÁ·¹ÀÌ
±âŸ
Á¦6Àå ¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå, ÀûÀÀÁõº°, 2020-2032³â
¾Ë·¹¸£±â Áúȯ
À§Àå Àå¾Ö
ÁßÃ߽Űæ°è Áúȯ
ÇǺΠÁúȯ
±âŸ
Á¦7Àå ¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå, Åõ¿© °æ·Îº°, 2020-2032³â
Á¦8Àå ¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå, À¯Çüº°, 2020-2032³â
Á¦9Àå ¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå, À¯Åë ä³Îº°, 2020-2032³â
º´¿ø ¾à±¹
¿Â¶óÀÎ ¾à±¹
¼Ò¸Å ¾à±¹
Á¦10Àå ¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå, Áö¿ªº°, 2020-2032³â
ºÏ¹Ì
À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
¶óƾ¾Æ¸Þ¸®Ä«
秵¾ÆÇÁ¸®Ä«
Á¦11Àå ±â¾÷ °³¿ä - ¼¼°èÀÇ Ç×È÷½ºÅ¸¹ÎÁ¦ ½ÃÀå
GlaxoSmithKline
ȸ»ç °³¿ä
Á¦Ç°/¼ºñ½º Æ÷Æ®Æú¸®¿À
À繫 ½ÇÀû
ÃÖ±Ù µ¿Çâ/¾÷µ¥ÀÌÆ®
Àü·« °³¿ä
Bayer AG
Almirall SA
Johnson and Johnson
Sanofi
Pfizer Inc.
Sun Pharmaceutical Industries Limited
Merck &Co. Inc.
Teva Pharmaceutical Industries Ltd.
Abbott Laboratories
Viatris Inc.
Arlak Biotech
Aden Healthcare
Sandoz Group AG
Hikma Pharmaceuticals PLC
Dr. Reddy's Laboratories
Cipla
Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý
KSA
¿µ¹® ¸ñÂ÷
Global Antihistamine Drugs Market is estimated to be valued at USD 101.74 Bn in 2025 and is expected to reach USD 167.80 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 101.74 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
7.40%
2032 Value Projection:
USD 167.80 Bn
Figure. Global Antihistamine Drugs Market Share (%), By Region 2025
Antihistamine drugs are a class of medications that are used to treat symptoms of allergies, such as sneezing, itching, runny nose, and watery eyes. These drugs work by blocking the action of histamine, a substance in the body that is released during an allergic reaction. There are two main types of antihistamines: First-generation antihistamines and second-generation antihistamine. Antihistamines are available over-the-counter and by prescription, depending on the specific medication and its strength. They come in various forms, including tablets, capsules, liquids, nasal sprays, and eye drops.
Market Dynamics:
The antihistamine drugs market is expected to witness significant growth over the forecast period owing to rise in the prevalence of allergies coupled, new product launches and approvals of innovative formulations. For instance, in June 2021, the U.S. Food and Drug Administration approved a nasal antihistamine for nonprescription use through a process known as a partial prescription to nonprescription switch. The U.S. FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis (also known as allergies) in adults and children aged six and older.
Key Features of the Study:
This report provides an in-depth analysis of the global antihistamine drugs market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global antihistamine drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Bayer AG, Almirall, S.A, GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer Inc., Sun Pharmaceutical Industries Limited, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Viatris Inc., Arlak Biotech, Aden Healthcare, Sandoz Group AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories, and Cipla
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global antihistamine drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antihistamine drugs market
Detailed Segmentation:
By Drug Class:
H-1 Antihistamines
First-generation
Second-generation
H-2 Antihistamines
By Form:
Liquid
Tablets
Capsules
Gels
Nasal Sprays
Others
By Indication:
Allergic Disorders
Gastrointestinal Disorders
Central Nervous System Disorders
Dermatological Disorders
Others
By Route of Administration:
By Type:
By Distribution Channel:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Bayer AG
Almirall S.A
GlaxoSmithKline
Johnson and Johnson
Sanofi
Pfizer Inc.
Sun Pharmaceutical Industries Limited
Merck & Co. Inc.
Teva Pharmaceutical Industries Ltd.
Abbott Laboratories
Viatris Inc.
Arlak Biotech
Aden Healthcare
Sandoz Group AG
Hikma Pharmaceuticals PLC
Reddy's Laboratories
Cipla
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Form
Market Snapshot, By Indication
Market Snapshot, By Route of Administration
Market Snapshot, By Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map
3. Key Insights
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition, and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Identification of Key Players in Each Region
Import-Export Analysis
Regulatory Scenario
Pricing Analysis
Product Recalls
4. Global Antihistamine Drugs Market, By Drug Class, 2020 - 2032 (US$ Billion)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2021 - 2032
Segment Trends
H-1 Antihistamines , 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
First-generation, 2020 - 2032(US$ Billion)
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Second-generation, 2020 - 2032(US$ Billion)
Market Size and Forecast, 2020 - 2032, (US$ Billion)
H-2 Antihistamines , 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
5. Global Antihistamine Drugs Market, By Form, 2020 - 2032 (US$ Billion)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2021 - 2032
Segment Trends
Liquid, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Tablets, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Capsules, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Gels, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Nasal Sprays, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Others , 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
6. Global Antihistamine Drugs Market, By Indication, 2020 - 2032 (US$ Billion)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2021 - 2032
Segment Trends
Allergic Disorders, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Gastrointestinal Disorders, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Central Nervous System Disorders, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Dermatological Disorders, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Others , 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
7. Global Antihistamine Drugs Market, By Route of Administration, 2020 - 2032 (US$ Billion)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2021 - 2032
Segment Trends
Oral, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Parenteral, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Others, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
8. Global Antihistamine Drugs Market, By Type, 2020 - 2032 (US$ Billion)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2021 - 2032
Segment Trends
OTC, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Prescription, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
9. Global Antihistamine Drugs Market, By Distribution Channel, 2020 - 2032 (US$ Billion)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2021 - 2032
Segment Trends
Hospital Pharmacies, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Online Pharmacies, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
Retail Pharmacies, 2020 - 2032(US$ Billion)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Billion)
10. Global Antihistamine Drugs Market, By Region, 2020 - 2032 (US$ Billion)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
Regional Trends
North America
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
Europe
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
Introduction
Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
South Africa
North Africa
Central Africa
11. Company Profiles - Global Antihistamine Drugs Market
GlaxoSmithKline *
Company Overview
Product/Service Portfolio
Financial Performance
Recent Developments/Updates
Strategic Overview
Bayer AG
Almirall S.A
Johnson and Johnson
Sanofi
Pfizer Inc.
Sun Pharmaceutical Industries Limited
Merck & Co. Inc.
Teva Pharmaceutical Industries Ltd.
Abbott Laboratories
Viatris Inc.
Arlak Biotech
Aden Healthcare
Sandoz Group AG
Hikma Pharmaceuticals PLC
Dr. Reddy's Laboratories
Cipla
12. References and Research Methodology
References
Research Methodology
About us and Sales Contact
°ü·ÃÀÚ·á